Benzinga | Aug 4, 2020 04:46PM EDT

Corcept Therapeutics Q2 EPS $0.32 Beats $0.22 Estimate, Sales $88.60M Miss $90.14M Estimate

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.22 by 45.45 percent. This is a 28 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $88.60 million which missed the analyst consensus estimate of $90.14 million by 1.71 percent. This is a 22.62 percent increase over sales of $72.26 million the same period last year.